BCL2 and neuroblastoma: In our therapeutic approach, ABT-199 eliminates this pro-survival BCL-2 signal, thus allowing for MYCN-mediated pro-apoptotic signaling to help push the neuroblastoma cells toward the apoptotic threshold.